We help the world’s largest pharmaceutical companies and healthcare brands to show patients, regulators, government, policy makers, doctors and media how their complex products deliver the thing we all value most: life.
Carolyn Paul has over 35 years of broad experience in the communications sector from journalism to public relations and from consumer brands to prescription pharmaceuticals, For the past 30 of those years Carolyn has focussed on international healthcare communications and is highly skilled at developing and directing global communications strategies and programmes; managing sensitive and complex issues; marketing pharmaceutical and consumer products; disseminating new policy, data or research-based information; driving corporate positioning programmes; implementing international media relations campaigns; leading community and professional advocacy initiatives; developed and developing world communications; devising and executing global events and campaigns: and creating and producing all types of communication material for delivery through traditional and non-traditional channels.
Carolyn’s expertise in the healthcare arena spans almost every sector including launching revolutionary pharmaceutical products (therapeutics and vaccines) and medical devices, and directing communications for organisations as diverse as Alzheimers Disease International and Unilever. Her work has touched upon numerous areas including almost every aspect of cardiovascular and metabolic disease, CNS disorders (including depression and Parkinson’s disease), HIV/AIDS, infectious disease, osteoporosis, allergy, immunology, oncology, rheumatology, respiratory disease and diagnostics.
Prior to joining Edelman, Carolyn was managing director at interSCIENCE London, where she designed and directed both global and national campaigns for a wide variety of clients and products. From 1993 to 2000 she directed global communications programmes for Merck & Co Inc.’s cardiovascular franchise (Zocor, Mevacor, Cozaar, Renitec and Aggrastat) which included the international launch of the results of the landmark Scandinavian Simvastatin Survival Study, which revolutionized prescribing patterns for cholesterol-lowering agents literally overnight. During this period, Carolyn also directed communications for Merck’s HIV product portfolio and launched new classes of therapy which began the evolution of HIV from a death sentence to a chronic disease.
Carolyn was previously Associate Director at Hill & Knowlton, where she was part of the team that launched the first nicotine patch in the UK and directed the global launch programmes of many other blockbuster products including Seroxat/Paxil and Clarityne. Carolyn was a leader of the team that supported Wellcome and Burroughs-Wellcome’s activities in HIV, including managing the outcome of controversial clinical trials of AZT and devising the first global programme of care, education and community support developed by any pharmaceutical company in the field.
At Edelman, Carolyn has particular responsibility for the development of global strategy, providing high level consultancy to senior clients and perfecting the design and execution of integrated global communications marketing campaigns, for clients who operate in multiple markets and regions around the world. Increasingly this involves creating campaigns which target the consumer as well as healthcare professionals, policy makers and payers. Carolyn is also frequently asked to bring her health expertise to bear for consumer clients in the beauty, food and nutrition sectors.
Eleanor joined Edelman in 2008 and has more than 15 years of experience in scientific and health communications.
A highly experienced science communicator and strategist, Eleanor has deep knowledge across a wide variety of therapeutic areas and scientific disciplines. She has overseen brand, franchise and corporate communications campaigns for health companies large and small. She has led teams delivering global and local market strategic communications directed towards HCPs, patients and payers. Eleanor's key area of interest is rooted in her science background; developing programs that deliver meaningful behavior change in the target audience through the application of evidence-based approaches.
Eleanor began her career in medical education programs and so has an in-depth understanding of not just the dissemination and amplification of peer-reviewed articles and scientific meetings, but also their content. Her therapeutic experience encompasses oncology, cardiovascular disease and diabetes, respiratory disease, autoimmune diseases, solid-organ transplantation, rare genetic disorders, osteoporosis, gout and nutrition.
In her current role as Managing Director of Health at Edelman UK, Eleanor is responsible for developing and driving the future vision and strategy of one of Europe's leading health communications businesses.
Eleanor received her Doctorate from King’s College London following on from a BSc in Pharmacology from Southampton University.
Group Client Director, EMEA
Angela focuses on client experience at Edelman, dedicated to advancing all aspects of the client-agency relationship where she puts clients at the core of our efforts.
Her experience is working as a client strategist with dozens of pharmaceutical and consumer healthcare companies globally, as well as leading on local implementation in the UK and US with regional work across Europe. Angela has extensive experience developing strategy for disease awareness campaigns, patient and healthcare provider engagement, data and regulatory milestone communications, corporate reputation and employee engagement.
It is her mission to empower strategists to earn the trust of the client’s business every day through relationships that inform strategic direction to meet the client’s business strategies and objectives.
Head of Operations, Health
Ashlea runs the operations for the health discipline at Edelman, a specialist, 50-strong team.
She has worked with pharmaceutical companies, NGOs and patient advocacy groups at global and regional levels to communicate our biggest health challenges today, and some of our most promising solutions to these. With a keen understanding of the global health landscape and health promotion, Ashlea leads integrated teams to deliver strategic, creative communications that are firmly grounded in insights.
Ashlea believes that our agency and work is only as strong as our people, and she is committed to growing and nurturing a team of diverse and exceptional consultants.